Why innovation in point-of-care diagnostics is needed
Challenge prizes offer a reward to whoever can first or most effectively solve a problem. The Longitude Prize is looking for a team of innovators from anywhere in the world to invent an affordable, accurate, fast and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time. £8 million will be awarded to the winner, to help tackle the global problem of antibiotic resistance.
Without accurate, rapid diagnostic tests and best practice in antibiotic stewardship, the efficacy of new antimicrobial medicines and treatments will be undermined in the long-term, while current stocks of antibiotics will be compromised in the short-term.
Delivered day-to-day by Challenge Works, the prize is supported by a committee of experts from across the scientific, clinical and industrial world. The Longitude Prize Committee and Advisory Panel is responsible for on-going prize consultation and will, ultimately, judge and decide which entry should win. Co-funded by Innovate UK and supported by BIRAC in India, other supporters of the Prize since 2014 include: GSK, BBC, Amazon, M&C and Science Museum.
The prize has now closed for entries and final assessment is taking place.
In 2014, Challenge Works, which exists to design challenge prizes that help solve pressing problems, initiated a competition for the UK public to decide the focus of the new Longitude Prize. Working with 100s of scientists, academics and others, the following issues were identified:
The choice of challenges was presented on BBC Horizon in 2014, with a poll opened to the public afterwards. The winner, Antibiotics, was subsequently announced on The One Show, on BBC One. Formally welcomed by then Prime Minister David Cameron, Innovate UK became a funding partner.
Entries are now closed.
Final submissions are now undergoing independent testing as the last stage of the assessment process.